# Eosera, Inc. – FDA Inspection, Mar 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/eosera-inc/6a760a07-14f0-4bff-8ac2-037a6b847e72
Source feed: FDA_Inspections

> FDA inspection 1308346 of Eosera, Inc., March 20, 2026. 10 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1308346
- Company Name: Eosera, Inc.
- Inspection Date: 2026-03-20
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 10

## Related Documents

- [FDA Inspection 1269635 - 2025-04-28](https://www.keypedia.com/records/fda_inspections/eosera-inc/d587b33b-e13d-4322-8bcc-32a754573761)
- [FDA Inspection 1165791 - 2022-03-01](https://www.keypedia.com/records/fda_inspections/eosera-inc/809c8c78-0695-434f-9552-a3a9c12e8c0c)
- [FDA Inspection 1115592 - 2020-01-17](https://www.keypedia.com/records/fda_inspections/eosera-inc/3221668e-fad4-4ca7-b173-8cba754bd210)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)
- [Issuing Officer](https://www.keypedia.com/people/milton-j-de-jesus-tavarez/24d4ed81-7c7e-42d2-8888-1c56c25eec67)
- [Oluwasefunm Agbanigo](https://www.keypedia.com/people/oluwasefunm-agbanigo/a25367a6-c32e-4706-9299-e90a15da2e95)
- [Oluwasefunmi Agbanigo](https://www.keypedia.com/people/oluwasefunmi-agbanigo/096acae0-9835-4ff1-8faa-c5ec6f551b21)

Company: https://www.keypedia.com/companies/eosera-inc/703b6159-ec09-448d-a592-b17026014ed1

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
